Ungbae Jeon

Prof. Dr. Ungbae Jeon

Pusan National University Yangsan Hospital, Yangsan, Gyeongnam, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2012 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
SPSung-Woo Park
Sung-Woo Park
JYJang Ho Yoon
Jang Ho Yoon
TKTae Hyo Kim
Tae Hyo Kim
JCJae Min Chung
Jae Min Chung
UJUngbae Jeon
Ungbae Jeon
WLWan Lee
Wan Lee

19 July 2016 in Acta Radiologica
Verified
Journal Article
Closed access
JJJoo Yeon Jang
Joo Yeon Jang
UJUngbae Jeon
Ungbae Jeon
JPJung Hwan Park
Jung Hwan Park
TKTae Un Kim
Tae Un Kim
JLJun Woo Lee
Jun Woo Lee
JRJe Ho Ryu
Je Ho Ryu
Hepatic venous outflow is important for graft survival in living donor liver transplantation (LDLT). If hepatic venous outflow obstruction occurs, hepatic vein stenting is considered to restore the patency. To retrospectively evaluate the efficacy and patency of primary hepatic vein stenting for hepatic venous outflow obstruction (HVOO) after LDLT. Percutaneous interventions, including hepatic vein stent placement with or without balloon angioplasty, were performed in 21 patients who had undergone LDLT and had HVOO confirmed through hepatic venography or manometry, including the patients who had a structural abnormality. Two stents each were inserted in four patients; therefore, the total number of treated anastomoses was 25. Technical success, patency rates, and pressure gradients between hepatic veins and the right atrium were evaluated in 19 patients each. Technical success was achieved in 25 of 26 vessels (96%). The mean interval between operation and stenting was 43 days. After the procedure, the follow-up period was a mean 530 days. The mean pressure gradient decreased from 8.5 mmHg to 2.1 mmHg after treatment (P < 0.01). The patency rates of the 25 vessels were 80% at 1, 2, and 3 years after stent placement. However, middle hepatic vein stenting revealed a low patency rate (all were 36%). Three of seven stents (43%) in the middle hepatic vein occluded during follow-up. Percutaneous primary hepatic vein stent replacement is an effective treatment for HVOO after LDLT.


16 December 2022 in Medicine
Verified
Journal Article
Open access
JKJin Hyeok Kim
Jin Hyeok Kim
UJUngbae Jeon
Ungbae Jeon
JJJooyeon Jang
Jooyeon Jang
TKTae Un Kim
Tae Un Kim
HRHwaseong Ryu
Hwaseong Ryu
JRJieun Roh
Jieun Roh
Simple renal cysts are the most common masses in the kidney. Most are asymptomatic and are incidentally detected on imaging examinations performed for other reasons. This study aimed to compare the results of 40 and 120 minutes ethanol sclerotherapies that were performed in a single session to treat incidentally found simple renal cysts. We retrospectively reviewed 63 renal cysts in 62 patients treated by single session percutaneous ethanol sclerotherapy. Thirty-one patients with 32 cysts underwent a 40 minutes sclerotherapy (group A), and 31 patients with 31 cysts underwent a 120 minutes retention technique (group B). Under ultrasonographic and fluoroscopic guidance, cystic fluid was completely aspirated, and 50% of the aspirated volume was replaced with 99.5% ethanol (a maximum of 100 mL). Imaging follow-up of the patients was performed 3 months after sclerotherapy. The technical success rates were 100% in both groups. Eighteen patients (29.0%) were symptomatic (flank pain or discomfort). Indications of the other patients were large cysts (>5 cm; 46%) and an increment in the diameter on serial studies (25.4%). A significant difference between the 2 groups in terms of age, cyst diameter, volume of aspirated fluid, volume of injected ethanol, and percentage of reduction in cyst diameter (P > .05) was not found. After treatment, flank pain or discomfort resolved in 17 of 18 (94.4%) symptomatic patients. One patient complained of persistent flank pain; however, no significant abnormality was detected on post-procedural computed tomography images. There were no other complications after therapy in the 2 groups. Single session ethanol sclerotherapy with a 40 minutes retention technique is an effective, safe, and cost-effective method for the treatment of incidentally found simple renal cysts. Although the procedural time was reduced, there was no significant difference in therapeutic efficacy between the 40 and 120 minutes therapies.

28 January 2022 in Diagnostic and Interventional Radiology
Verified
Journal Article
Closed access
JKJin Hyeok Kim
Jin Hyeok Kim
UJUngbae Jeon
Ungbae Jeon
CKChang Won Kim
Chang Won Kim
HLHyun Jung Lee
Hyun Jung Lee
JJJoo Yeon Jang
Joo Yeon Jang
HKHoon Kwon
Hoon Kwon
To evaluate the embolic effect of fish-derived gelatin microparticles (GMPs) and compare the degradation periods and biocompatibilities of different molecular weight (MW) GMPs in a rabbit model. GMPs were designed to degrade within 21 days (high MW GMP, 15-30 kDa) and 2 days (low MW GMP, 5-15 kDa) in vivo. Renal arteries of 24 rabbits were embolized using both high and low MW GMPs (155-350 µm). Rabbits were sacrificed either immediately after embolization, or after follow-up (F/U) angiogram on days 2 and 21 of embolization, respectively (4 rabbits in each of the 6 subgroups). Pathological changes of recanalized vessels were evaluated using the Banff classification. For the in vitro study, each type of GMP was mixed with normal saline and morphological changes were compared for 14 days. Fish-derived GMPs showed effective embolization. On 2-day F/U angiography, occluded vessels were more recanalized to the peripheral branches in low MW group. On day 21, a parenchymal perfusion defect recovered to a greater extent in low MW group than that in high MW group. Mean Banff scores for intimal arteritis on 2-day F/U and interstitial fibrosis on 21-day F/U were higher in high MW group (1.75 ± 0.58 vs. 0.19 ± 0.4 and 2.56 ± 0.63 vs. 0.88 ± 0.89; P < .001). On in vitro assessment, low MW GMP lost the spherical shape and degraded, and was invisible on microscopy on day 6, whereas high MW GMP was only partially degraded after 2 weeks. Fish-derived GMPs showed effective embolization in a rabbit model. Low MW GMPs degraded within 2 days with a low inflammatory response.

10 December 2021 in Medicine
Verified
Journal Article
Open access
JJJooyeon Jang
Jooyeon Jang
UJUngbae Jeon
Ungbae Jeon
JKJin Hyeok Kim
Jin Hyeok Kim
TKTae Un Kim
Tae Un Kim
HRHwaseong Ryu
Hwaseong Ryu
KYKi Tae Yoon
Ki Tae Yoon
Rationale: Most gastric varices at the fundus drain into the left renal vein via the gastrorenal shunt (80–85% of cases) or the inferior vena cava via the gastrocaval shunt (10–15%). Therefore, plug-assisted retrograde transvenous obliteration (PARTO) is usually performed via a gastrorenal shunt. Here, we report a case of gastric varix treated with PARTO via a gastrocaval shunt. Patient concerns: A 46-year-old woman with hepatitis B virus and liver cirrhosis visited the emergency room in our hospital with the main symptom of hematemesis and hematochezia. Diagnoses: Endoscopy and computed tomography (CT) revealed a gastric varix and thrombotic-occluded transjugular intrahepatic portosystemic shunt (TIPS) stent. Interventions: The patient underwent PARTO via a gastrocaval shunt to manage gastric variceal bleeding after failed TIPS revision. Outcomes: On CT, the gastric varix completely disappeared. The patient did not experience any additional bleeding events. Lessons: PARTO via a gastrocaval shunt is safe and effective.